All Supplements
    Supplement

    FisetinNew

    Supplement
    Polyphenols
    4/10 Evidence

    Fisetin is a plant flavonoid (concentrated in strawberries) that became one of the most closely watched senolytic candidates after preclinical work showed it could selectively clear senescent "zombie" cells; in aged mice, late-life fisetin reduced senescence markers and modestly extended median and maximum lifespan (Yousefzadeh et al., EBioMedicine, 2018). Translating that promise to people has been slower, and the human evidence remains early and mixed. A 2026 structured review in Nutrients catalogued 34 registered fisetin clinical trials but found only four completed with reported results, concluding that clinical evidence is still limited and heterogeneous. On the encouraging side, a 2026 randomized controlled trial in men with obesity found that fisetin 200 mg/day for 12 weeks significantly lowered the inflammatory markers IL-6 and TNF-alpha even without exercise, and reduced fasting glucose, insulin and HOMA-IR. On the cautious side, a Mayo Clinic-led randomized, placebo-controlled trial in knee osteoarthritis using intermittent high-dose senolytic cycles reported no significant improvement in pain, function or cartilage versus placebo, despite good tolerability. Larger randomized trials are ongoing in systemic inflammation (suPAR), sepsis, long COVID and peripheral artery disease. Given the gap between strong mechanistic/animal data and still-preliminary human outcomes, fisetin is best regarded as an investigational, not proven, longevity intervention; discuss realistic expectations with your physician before use. This is educational information, not medical advice or a claim to diagnose, treat, cure or prevent any disease.

    Mechanism of Action

    Fisetin is proposed to act as a senolytic by selectively triggering apoptosis in senescent cells, which resist normal cell death and accumulate with age while secreting pro-inflammatory factors (the senescence-associated secretory phenotype, or SASP). Preclinical work suggests it acts partly by disrupting the pro-survival signaling that senescent cells depend on - including the PI3K/AKT and FOXO4-p53 pathways - alongside antioxidant and NF-kB-modulating anti-inflammatory activity. Most of this evidence comes from cell and animal models; the exact human dose and exposure needed to reproduce senolytic effects have not been established, and fisetin has naturally low oral bioavailability.

    Latest Research

    Reviewed Oct 24, 2026

    Fisetin is a plant flavonoid (concentrated in strawberries) that became one of the most closely watched senolytic candidates after preclinical work showed it could selectively clear senescent “zombie” cells. In aged mice, late-life fisetin reduced senescence markers and modestly extended median and maximum lifespan. Translating that promise to people has been slower, and the human evidence is still early and mixed. A 2026 structured review in Nutrients catalogued 34 registered fisetin clinical trials but found only four completed with reported results, concluding that clinical evidence remains limited and heterogeneous. On the encouraging side, a 2026 randomized controlled trial in men with obesity found that fisetin 200 mg/day for 12 weeks significantly lowered the inflammatory markers IL-6 and TNF-α even without exercise (shown below), and also reduced fasting glucose, insulin and HOMA-IR. On the cautious side, a Mayo Clinic-led randomized, placebo-controlled trial in knee osteoarthritis using intermittent high-dose senolytic cycles reported no significant improvement in pain, function or cartilage versus placebo, despite good tolerability. Larger randomized trials are now underway in systemic inflammation (suPAR), sepsis, long COVID and peripheral artery disease. Bottom line: fisetin has strong mechanistic and animal data but still-preliminary human outcomes, and is best framed as investigational rather than proven. This is educational information, not medical advice or a claim to diagnose, treat, cure or prevent any disease — discuss supplementation with your physician, particularly if you take anticoagulants, are scheduled for surgery, or are pregnant or breastfeeding.

    Randomized Trial · Men with obesity · 12 weeks (fisetin-only arm, n≈11)

    Fisetin Alone Lowered Inflammatory Markers in a 12-Week RCT

    Plasma IL-6 and TNF-α before and after 12 weeks of fisetin 200 mg/day (shorter = less inflammation)

    In a 2026 randomized controlled trial in men with obesity, the fisetin-only arm (200 mg/day, no exercise; n≈11) showed significant within-group reductions in two key inflammatory markers over 12 weeks: IL-6 fell from 2.06 to 1.59 pg/mL (P = 0.013) and TNF-α from 4.37 to 3.21 pg/mL (P = 0.002); fasting glucose, insulin and HOMA-IR also improved. This is a single, small trial in a specific population, and the effects were larger when fisetin was combined with exercise. Source: Alipour et al., Journal of the International Society of Sports Nutrition, 2026 (doi:10.1080/15502783.2026.2679718).

    Dosing Protocol

    Recommended

    100-500mg daily, or intermittent high-dose senolytic cycles (research protocols use ~20mg/kg for 2 consecutive days, repeated monthly)mg

    Standard starting dose based on research

    Therapeutic Range

    100

    Minimum

    to

    1500

    Maximum

    mg

    With a meal containing fat to aid absorption

    Cycling Protocol

    Some longevity practitioners and research protocols use intermittent 'hit-and-run' senolytic dosing (e.g., a large dose on 2 consecutive days, then weeks off) rather than daily use, based on the theory that senescent cells only need to be transiently targeted; this pattern was used in the Mayo Clinic knee osteoarthritis trial (3 cycles of 20mg/kg for 2 days, 28 days apart) but did not outperform placebo, so optimal human cycling is unproven.

    Dosages are general guidelines. Individual requirements vary based on body weight, health status, and specific goals. Start with lower doses and adjust based on response.

    Benefits

    Primary Benefits

    • Senescent cell clearance (preclinical)
    • Reduction of inflammatory SASP markers
    • Antioxidant support
    • Cartilage/joint cell health (studied, not proven)

    Secondary Benefits

    Skin/dermal senescence support
    General anti-inflammatory support

    Safety Information

    Contraindications

    Do not use if any of the following apply:

    • •Pregnancy and breastfeeding (insufficient safety data)
    • •Known bleeding disorders or anticoagulant use (theoretical antiplatelet effect at high doses)
    • •Upcoming surgery

    Drug/Supplement Interactions

    May interact with the following. Consult a healthcare provider before combining:

    May affect drug-metabolizing enzymes (CYP450) at high doses; caution with other medications metabolized by the liver

    Potential Side Effects

    Some users may experience:

    Generally well tolerated in trials to date
    GI discomfort at high doses
    Headache (uncommon)

    This is not a complete list of interactions or side effects. Individual responses vary. Always start with the lowest effective dose and monitor your response. Report any adverse effects to your healthcare provider.

    Quality Markers

    Look for these specific quality indicators when sourcing this compound:

    • Third-party tested for purity/heavy metals
    • Enhanced-bioavailability forms (liposomal or complexed) given fisetin's naturally poor oral absorption
    • Standardized extract with verified fisetin content (not just fruit powder)

    Trusted Certifications

    NSF Certified
    USP Verified
    GMP Certified
    ConsumerLab Approved

    Note: Supplement quality varies dramatically between brands. Cheap supplements often contain fillers, incorrect doses, or contaminants. Investing in quality products from reputable manufacturers is essential for safety and efficacy.

    Evidence Profile

    Evidence Score

    4/10

    Emerging/Anecdotal

    Limited clinical data, primarily mechanistic studies or user reports

    Classification:
    Emerging Evidence

    Evidence Scale

    8-10

    Strong

    5-7

    Moderate

    1-4

    Emerging

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation